Is there a patient assistance program for fasenra?

Fasenra Patient Assistance Program

Fasenra, known generically as benralizumab, is a medication used for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps. There are patient assistance programs available for this medication. [1]

Free Fasenra Samples

AstraZeneca, the manufacturer of Fasenra, offers a free Fasenra sample program. This program provides eligible patients with a complimentary supply of Fasenra for a specified period. However, the eligibility criteria and specific details may vary depending on the patient's location and insurance status.

Fasenra Patient Assistance Program Eligibility

To be eligible for the Fasenra patient assistance program, patients typically need to meet certain requirements, such as:

* Being a resident of the United States
* Having a valid prescription for Fasenra
* Not having any insurance coverage or having insurance with high out-of-pocket costs
* Being unable to pay for the medication
* Meeting income and asset requirements

How to Enroll in the Fasenra Patient Assistance Program

Patients can request enrollment in the Fasenra patient assistance program through AstraZeneca's Access Support website [2] or by calling their toll-free number at 1-800-AZandMe (1-800-292-6363). They will then be given instructions on how to apply.

Alternative Options

For patents who do not qualify for or are not eligible for the Fasenra patient assistance program, other options exist. Some patient advocacy groups and non-profit organizations, like the Patient Access Network (PAN) Foundation, provide financial assistance for medications, including Fasenra.

When Does Fasenra Exclusivity Expire?

The patent for Fasenra is set to expire on a specific date. However, this information is subject to change and could be different from the current patent details available on DrugPatentWatch.com [3].

Sources:

[1] AstraZeneca. (n.d.). Fasenra Patient Access. Retrieved from https://www.astrazeneca-us.com/our-medicines/medicine-list/fasenra-patient-access.html

[2] AstraZeneca. (n.d.). Access Support. Retrieved from https://www.astrazeneca-us.com/patient-support/access-support.html

[3] DrugPatentWatch.com. (n.d.). Benralizumab Patent Expiration. Retrieved from https://www.drugpatentwatch.com/patents/Benralizumab